Limited Utility of HIV RNA Testing to Monitor Oral Preexposure Prophylaxis Use: A Real-World Cohort Study—United States, 2019–2023
HIV RNA testing did not provide additional value to Ag/Ab testing during routine follow-up of oral PrEP users. Considering the cost and logistical complexity of HIV RNA testing, its use as a routine test during follow-up of oral PrEP users warrants reconsideration.
Authors
- Weiming Zhu (ORCID: https://orcid.org/0000-0002-9042-6202)
- Kevin P. Delaney (ORCID: https://orcid.org/0000-0002-7562-7647)
- Karen W. Hoover (ORCID: https://orcid.org/0000-0003-4942-7905)
- Rupa Patel (ORCID: https://orcid.org/0000-0002-0329-7036)
- Athena P. Kourtis (ORCID: https://orcid.org/0000-0003-1585-1310)
- Ya-Lin A. Huang (ORCID: https://orcid.org/0000-0003-3137-8594)
Institutions
- Centers for Disease Control and Prevention (US)
- Centers for Disease Control and Prevention (UG)
- The Centers (US)
- Centers for Disease Control and Prevention (KE)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2025-05-03
- DOI
- https://doi.org/10.1093/cid/ciaf230
- Citations
- 1
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 1.40